Author

Bilal A. Lone

National Institutes of Health

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Approach:statistical model· 3 Assay:bulk RNA-seq· 2 Research Focus:chromatin & epigenetic regulation· 2 Research Focus:differential expression· 2 Assay:DNA methylation· 2 Approach:experimental assay· 2 Assay:whole-genome sequencing· 2

Frequent Co-Authors

Abdul Rouf BandayiD· 3 shared Dhanusha YesudhasiD· 2 shared Ecem Ünal· 2 shared KM Butler· 2 shared Abbas Yousefi-Rad· 1 shared Andrea Borghese ApoloiD· 1 shared Arup Chakraborty· 1 shared Ayşe Gökçe KeşküşiD· 1 shared

Activity by Year

2026-2026 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Abdul Rouf BandayORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

APOBEC3 activity and polymerase-ε deficiency are associated with distinct IDH1 R132 hotspot mutations

Kelly E. Butler, Bilal A. Lone, Ecem Ünal, Abdul Rouf Banday

The paper identifies distinct mutational mechanisms for IDH1 R132 hotspot mutations, linking APOBEC3 activity to R132C and polymerase-ε deficiency to R132H.

bioRxiv · Jul 13, 2026 · PreprintCancer Biology

APOBEC3G expression marks a TMB-high, T cell-inflamed tumor state and is associated with response to immune checkpoint blockade in multiple cancer cohorts

KM Butler, Dhanusha Yesudhas, Bilal A. Lone, Abdul Rouf Banday

This study identifies APOBEC3G as a transcriptomic marker associated with high TMB, T cell infiltration, and response to immune checkpoint blockade across multiple cancer cohorts.

bioRxiv · Jul 13, 2026 · PreprintGenomics

APOBEC3-driven neoantigen-rich cancers co-opt 1q23.3 amplification for tumor-intrinsic immune cloaking

Dhanusha Yesudhas, Bilal A. Lone, Ecem Ünal, Arup Chakraborty, Ayşe Gökçe Keşküş, Jaimie Ryou, KM Butler, Tania Colon Aquino, Abbas Yousefi-Rad, Weiming Yang, Lisa M. Miller Jenkins, Raju R. Chelluri, Elias B. A. Chandran, Vladimir Valera Romero, Salah Boudjadi, , Abdul Rouf Banday

The paper identifies a tumor-intrinsic immune-cloaking mechanism in neoantigen-rich cancers driven by APOBEC3 mutagenesis and 1q23.3 amplification, showing NECTIN4's role in suppressing immune responses.

bioRxiv · Jul 4, 2026 · PreprintCancer Biology